[News Brief] Sonire Therapeutics Receives NEDO Support for HIFU Platform
Sonire Therapeutics KK has received funding through Japan’s New Energy and Industrial Technology Development Organization (NEDO) Deep-Tech Startups Support Program…
Pharmaceuticals & Supplements
[News Brief] Axcelead DDP Joins Eli Lilly TuneLab Collaboration
Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, an artificial intelligence and machine learning drug…
[News Brief] Innovent Biologics and Pfizer Sign Oncology Collaboration
China-based Innovent Biologics and Pfizer have entered a global licensing and collaboration agreement to research and develop twelve early-stage cancer…
[News Brief] Haisco Pharma and Eli Lilly Sign Research Collaboration
China-based Haisco Pharmaceutical Group has entered a licensing and research collaboration with Eli Lilly and Company to discover and develop…
[News Brief] Everest Medicines Licenses Kidney Disease Therapy to Travere
China-based Everest Medicines has entered an exclusive licensing and collaboration agreement with US-based Travere Therapeutics for the development and commercialisation…
[News Brief] Daewoong Pharma Partners for Dupilumab Biosimilar Development
South Korea-based Daewoong Pharmaceutical has partnered with China-based Chime Biologics to develop and manufacture a dupilumab biosimilar candidate referencing Dupixent.…
[News Brief] FDA Approves Tremfya Label Expansion for Psoriatic Arthritis
The US Food and Drug Administration (FDA) has approved a label expansion for Tremfya (guselkumab) to include evidence for inhibition…
[News Brief] Pfizer Receives FDA Approval for Expanded Hympavzi Use
Pfizer has received US Food and Drug Administration (FDA) approval for an expanded indication of Hympavzi (marstacimab-hncq) for adults and…
[News Brief] Everest Medicines Licences Sumecigrel for Asia-Pacific Development
Everest Medicines has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co. for the development, registration and commercialisation…
[News Brief] PharmaEssentia Receives Taiwan Approval for Besremi in ET
PharmaEssentia Corporation has received approval from Taiwan’s Ministry of Health and Welfare for Besremi (ropeginterferon alfa-2b) for the treatment of…